New research in the October 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network assessed patient satisfaction and preferences for telemedicine, finding 45% of people with cancer preferred telemedicine, while 34% preferred office visits, and 21% had no preference.
Researchers from Memorial Sloan Kettering Cancer Center (MSK) reviewed patient surveys before and during the COVID-19 pandemic, found higher percentage preferred telemedicine and that general patient satisfaction scores were equally high for both video conferencing and office visits